系统性红斑狼疮对下肢大截肢的影响:危险因素与康复
本研究回顾性分析608例下肢大截肢患者,其中14例(2.3%)确诊系统性红斑狼疮(SLE)。SLE患者围手术期及术后结局与非SLE患者相当或更优,假肢使用与生存改善正相关,术后SLE药物管理似乎对最佳结局至关重要。
要点
- SLE患者下肢大截肢围手术期及术后结局与非SLE患者相当或更优。
- 假肢使用与SLE患者生存改善呈正相关。
- 术后SLE药物管理似乎对最佳结局至关重要,具体方案需进一步研究。
核心结论
- SLE患者行下肢大截肢的围手术期及术后结局与非SLE患者相当或更优。
- 假肢使用与生存改善呈正相关。
- 术后SLE药物管理似乎对最佳结局至关重要,具体细节需进一步研究。
研究设计与样本
- 回顾性病历审查,纳入2014年至2022年间接受下肢大截肢的608例患者,其中14例(2.3%)确诊SLE。
主要发现
- SLE队列中位年龄57岁,57%为女性;常见合并症包括既往吸烟史36%、当前吸烟29%、糖尿病50%、外周动脉疾病79%、血液系统疾病57%。
- 术前36%发生深静脉血栓,7.1%发生肺栓塞;截肢指征为严重肢体缺血64%、感染21%、外周动脉疾病/外周血管疾病7.1%、肉瘤7.1%。
- 术后伤口感染50%、深静脉血栓14%、肺栓塞7.1%;36%患者出院时调整药物以更好管理SLE,术后未记录到狼疮 flare。
- 1年独立行走64%,使用假肢50%;5年生存率57%。
临床怎么用
- SLE患者行下肢大截肢的围手术期及术后结局与非SLE患者相当或更优。
- 假肢使用与生存改善正相关。
- 术后SLE药物管理似乎对最佳结局至关重要,具体方案需进一步研究。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic lupus erythematosus (SLE) is associated with hypercoagulability and impaired wound healing, raising concerns about surgical outcomes in SLE patients undergoing major lower extremity amputation (MLEA). This study compares perioperative outcomes in SLE versus non-SLE patients to determine if MLEA is equally safe for both groups. METHODS: A retrospective chart review of 608 patients who underwent MLEA between 2014 and 2022 was conducted. Of these, 14 patients (2.3%) had confirmed SLE. Data were collected and analyzed regarding demographics, preoperative risks, perioperative events, postoperative outcomes, and survival. RESULTS: Among the SLE cohort, the median age was 57 and 57% were female. Common comorbidities included prior smoking history (36%), current smokers (29%), diabetes (50%), peripheral artery disease (79%), and hematological disorders (57%). Preoperatively, 36% experienced deep vein thrombosis, and 7.1% suffered a pulmonary embolism. Indications for amputation included critical limb ischemia (64%), infection (21%), peripheral artery disease/peripheral vascular disease (7.1%), and sarcoma (7.1%). Forty-three percent underwent transfemoral and 57% underwent transtibial amputations, averaging 106 minutes of surgical time with 209 mL blood loss. Postoperatively, wound infection occurred in 50%, deep vein thrombosis in 14%, and 7.1% suffered pulmonary embolisms. Medication adjustments at discharge were made in 36% of patients to better manage SLE, and no lupus flare-ups were documented postoperatively. Independent ambulation at 1 year was achieved by 64%, with 50% utilizing prostheses. Five-year survival was 57%. CONCLUSIONS: Perioperative and postoperative outcomes in SLE patients undergoing MLEA were comparable to or better than non-SLE patients. Prosthetic use was positively correlated with improved survival. Postoperative SLE medication management appears essential for optimal outcomes, with specifics warranting further investigation.
引用
- Wetoska N, Shiva A, Nagarsheth K, et al. The Impact of Systemic Lupus Erythematosus on Major Lower Extremity Amputation: Risk Factors and Recovery. Ann Vasc Surg. 2025. PMID: 40553840. doi:10.1016/j.avsg.2025.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。